University of Stuttgart develops urine-based Biobeton as low‑carbon alternative to Portland cement

Researchers at the University of Stuttgart have demonstrated a significant step towards a low‑carbon alternative to Portland cement by producing a load‑bearing “Biobeton” using biomineralisation and human urine as a feedstock. According to the university, the material is formed when urease‑active microbes precipitate calcium carbonate that binds packed sand grains into a stone‑like matrix without the high‑temperature kiln firing typical of conventional cement production.

The Stuttgart team combined several process and material advances to overcome two long‑standing barriers for microbial binders: insufficient compressive strength and shallow effective build depth. By optimising grain size distribution to maximise pack density, using an urease‑active calcium carbonate powder rather than free‑floating bacteria, and applying an automated stop‑flow nutrient infusion that slowly forces the urea‑rich solution through the compacted bed, they produced test specimens reaching up to 52.5 MPa compressive strength across 140 mm depth and single points of 57.4 MPa. Those values push the material beyond the C20/25 threshold used for many prefabricated structural elements. The researchers emphasise that “Urin ist kein exotischer Stoff, sondern ein stetig verfügbarer Rohstoffstrom”, Lucio Blandini, head of the Institute for Lightweight Design, said at a public collection event.

The process replaces the energy‑intensive calcination step in clinker production , typically performed at about 1,450°C and responsible for process CO₂ emissions , with a biologically driven mineralisation that, in net, fixes CO₂ into carbonate rather than releasing it. According to the project team and public reporting, that change offers a markedly improved emissions profile for components that can be manufactured under controlled, industrial conditions.

Industry‑relevant caveats remain. The elastic modulus of the Biobeton measured at 11–12 GPa is lower than typical Portland cement concretes used for heavy‑duty slabs, meaning applications such as bridge decks or high‑span floor systems would still require supplementary reinforcement or hybrid design approaches. The method also demands precise material packing and slow, automated nutrient delivery; it is unsuited to improvised, on‑site casting without industrial control. The Stuttgart researchers therefore envisage initial deployment in standardised, prefabricated wall, façade and other modular components where geometry and production conditions can be tightly controlled.

A central scaling question is supply of urea. Industrial urea production is itself energy‑intensive, so the team is exploring circular resource flows in which human urine , which already contains dissolved urea and water , supplies much of the reagent demand. At the CMT tourism fair in Stuttgart the university piloted urine collection from campers to test logistics and public engagement. According to the university’s announcement, that activity is part of the SimBioZe project, which aims to close loops between wastewater treatment, fertiliser recovery and building material manufacture so that both construction feedstock and nutrient products can be derived from the same waste stream.

Independent press coverage and the university’s public communications describe the SimBioZe concept as a pragmatic, place‑based model: urine and wastewater streams from high‑throughput sites such as airports, stations or large events could be aggregated and treated to feed prefabrication plants. The approach, the university says, is intended to be complementary rather than replacement‑oriented; Biobeton is not presented as a direct one‑for‑one substitute for all Portland cement applications but as a low‑carbon option for selected prefabricated load‑bearing components where its performance envelope and production mode fit industrial practice.

Technical drivers identified by the researchers are instructive for industry actors pursuing decarbonisation: pack density of the aggregate is a stronger lever on strength than increasing microbial load; excessively high nutrient flow rates lead to inhomogeneous carbonate deposition and weaker material; and integrated process control yields the most consistent results. Those insights shift attention away from scaling biological inputs per se to engineering the granular system and the delivery regime , areas where manufacturing engineering and supply‑chain integration can have outsized impact.

For practitioners in industrial decarbonisation, Biobeton presents both a technological opportunity and a systems challenge. If material performance and prefabrication economies hold at scale, the approach could reduce embodied process emissions for many building components. Realising that potential will require investments in feedstock collection and treatment, standardised production lines, updated design guidance to account for lower stiffness, and supply‑chain arrangements that internalise wastewater and nutrient recovery as part of circular material streams.

The research, and the public pilot at CMT, underline the hybrid nature of the solution: microbiology delivers the chemistry, but engineering and logistics determine whether the material can be produced reliably and at scale. According to coverage in technology and regional media, the University of Stuttgart considers Biobeton a pragmatic, incremental pathway for reducing the carbon intensity of prefabricated building elements while broader substitution of Portland cement continues to be constrained by performance, regulation and market scale.